scispace - formally typeset
R

Ruurd Torensma

Researcher at Radboud University Nijmegen

Publications -  171
Citations -  13552

Ruurd Torensma is an academic researcher from Radboud University Nijmegen. The author has contributed to research in topics: Antigen & Immune system. The author has an hindex of 48, co-authored 171 publications receiving 12918 citations. Previous affiliations of Ruurd Torensma include Stanford University & Philips.

Papers
More filters
Journal ArticleDOI

DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells

TL;DR: It is proposed that DC-SIGN efficiently captures HIV-1 in the periphery and facilitates its transport to secondary lymphoid organs rich in T cells, to enhance infection in trans of these target cells.
Journal ArticleDOI

Identification of DC-SIGN, a Novel Dendritic Cell–Specific ICAM-3 Receptor that Supports Primary Immune Responses

TL;DR: It is demonstrated that ICAM-3 expressed by resting T cells is important in this first contact with dendritic cells, and it is predicted that DC-SIGN enables T cell receptor engagement by stabilization of the DC-T cell contact zone.
Journal ArticleDOI

Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting

TL;DR: How direct targeting of antigens to DC surface receptors in vivo might replace laborious and expensive ex vivo culturing, and facilitate large-scale application of DC-based vaccination therapies is discussed.
Journal ArticleDOI

Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors

TL;DR: It is demonstrated that cytokine production by human mononuclear cells or murine macrophages was markedly reduced when stimulated by C. albicans mutants defective in mannosylation and recognition of C.Albicans by monocytes/macrophages is mediated by 3 recognition systems of differing importance, each of which senses specific layers of the C. Albicans cell wall.
Journal ArticleDOI

Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes

TL;DR: The appearance of cytomegalovirus antigen positive blood leucocytes (CMV antigenaemia) was investigated in 52 renal transplant recipients during the first three months after transplantation and results were related to virus isolation from buffy coats, serology with a sensitive enzyme‐linked immunosorbent assay (ELISA), and clinical symptoms of CMV disease.